Verification of EZH2 as a druggable target in metastatic uveal melanoma

被引：0
|
作者：
Bei Jin
Ping Zhang
Hailin Zou
Huijing Ye
Yun Wang
Jing Zhang
Huasheng Yang
Jingxuan Pan
机构：
[1] Sun Yat-sen University,State Key Laboratory of Ophthalmology, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Zhongshan Ophthalmic Center
来源：
Molecular Cancer | / 19卷
关键词：
Uveal melanoma; EZH2; Hepatic metastasis; Motility; Cancer stem-like cells;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [21] EZH2 as a Potential Target for NAFLD Therapy
    Lim, Hyun Jung
    Kim, Mirang
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (22) : 1 - 15
  • [22] Ezh2, A NOVEL TARGET IN TREATMENT OF MEDULLOBLASTOMA
    Ricke, Brandon
    Shah, Kushal
    Salacz, Michael
    Camarata, Paul
    Lovick, Darren
    Peng, Warner
    Dolatkhah, Roya
    Sanaat, Zohreh
    Kimura, Kyle
    Bi, Danse
    Taylor, Sarah
    Esfandyari, Tuba
    Farassati, Faris
    NEURO-ONCOLOGY, 2015, 17 : 36 - 36
  • [23] EZH2 as a potential target in cancer therapy
    McCabe, Michael T.
    Creasy, Caretha L.
    EPIGENOMICS, 2014, 6 (03) : 341 - 351
  • [24] EZH2: a novel target for cancer treatment
    Duan, Ran
    Du, Wenfang
    Guo, Weijian
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [25] EZH2: a novel target for cancer treatment
    Ran Duan
    Wenfang Du
    Weijian Guo
    Journal of Hematology & Oncology, 13
  • [26] OVEREXPRESSION OF Ezh2 AS A TARGET IN TREATMENT OF GLIOMA
    Farassati, Faris
    Peng, Warner
    Lovick, Darren
    Shah, Kushal
    Ricke, Brandon
    NEURO-ONCOLOGY, 2016, 18 : 59 - 60
  • [27] LncRNA PVT1 knockdown affects proliferation and apoptosis of uveal melanoma cells by inhibiting EZH2
    Huang, X. -M.
    Shi, S. -S.
    Jian, T. -M.
    Tang, D. -R.
    Wu, T.
    Sun, F. -Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (07) : 2880 - 2887
  • [28] EZH2 as molecular target for Glioblastoma treatment
    Scheffler, J.
    Freitag, T.
    Ramtke, J.
    Kaps, P.
    Dubinski, D.
    Junghanss, C.
    Maletzki, C.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 89 - 89
  • [29] Enhancer of zeste homolog 2 (EZH2) inhibition in metastatic melanoma promotes tumor regression in vivo
    Sengupta, Deepanwita
    Avaritt, Nathan
    Shalin, Sara C.
    Tackett, Alan J.
    CANCER RESEARCH, 2016, 76
  • [30] Expression of EZH2 and ALDH1 in Metastatic Malignant Melanoma Affects Survival.
    Queenan, M. B.
    Brody, J.
    Potoczek, M.
    Berger, A.
    Solomides, C.
    McCue, P.
    Witkiewicz, A. K.
    MODERN PATHOLOGY, 2011, 24 : 124A - 124A
12345